Methods for treating extreme insulin resistance in patients resistant to previous treatment with other anti-diabetic drugs employing an SGLT2 inhibitor and compositions thereof | Patent Application Number 13321103

13321103
Not Appealed
Patent NumberUS 08685934 B2
Publication NumberUS 20120071403 A1
Filled DateMay 26, 2010
Priority DateMay 27, 2009
Inventor/ApplicantsPaul Strumph
Stephanie Moran
James List
ExaminesWEDDINGTON, KEVIN E
Art Unit1629
Technology Center1600
Assignments
Astrazeneca
Current
Astrazeneca
Original
Bristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.